LeMaitre Vascular, Inc. (LMAT) P/E Ratio History
UndervaluedTrading at 32.1x vs 5Y avg 44.3x · 0th percentile · Below historical baseline · Data 2009–2026
Loading P/E history...
P/E Ratio Analysis
As of September 24, 2026, LeMaitre Vascular, Inc. (LMAT) trades at a price-to-earnings ratio of 32.1x, with a stock price of $80.82 and trailing twelve-month earnings per share of $2.68.
The current P/E is 28% below its 5-year average of 44.3x. Over the past five years, LMAT's P/E has ranged from a low of 32.3x to a high of 59.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.7x, LMAT trades at a 35% premium to its sector peers. The sector includes 225 companies with P/E ratios ranging from 0.0x to 164.5x.
The PEG ratio of 1.66 (P/E divided by 31% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, LMAT commands a significant premium over the S&P 500 median P/E of 24.8x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our LMAT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
LMAT Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
LMAT P/E vs Peers
Surgical and interventional devices peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $1B | 29.9 | 0.82Best | -65% | |
| $5B | 41.0 | - | +5% | |
| $3B | 17.2Lowest | - | +382%Best | |
| $231M | 32.4 | 2.52 | +48% | |
| $4B | 86.0 | 57.57 | +104% | |
| $66B | 23.0 | - | +55% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
LMAT Historical P/E Data (2009–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | - | $95.96 | $2.85 | 33.7x | -14% |
| FY2026 Q1 | - | $109.17 | $2.71 | 40.3x | +3% |
| FY2025 Q4 | Dec 31 2025 | $81.10 | $2.51 | 32.3x | -17% |
| FY2025 Q3 | - | $87.51 | $2.32 | 37.7x | -3% |
| FY2025 Q2 | Jun 30 2025 | $83.05 | $2.06 | 40.3x | +3% |
| FY2025 Q1 | Mar 31 2025 | $83.90 | $1.98 | 42.4x | +9% |
| FY2024 Q4 | - | $92.14 | $1.93 | 47.7x | +23% |
| FY2024 Q3 | Sep 30 2024 | $92.89 | $1.82 | 51.0x | +31% |
| FY2024 Q2 | Jun 30 2024 | $82.28 | $1.66 | 49.6x | +27% |
| FY2024 Q1 | Mar 30 2024 | $66.36 | $1.50 | 44.2x | +14% |
| FY2023 Q4 | Dec 31 2023 | $56.76 | $1.34 | 42.4x | +9% |
| FY2023 Q3 | Sep 30 2023 | $54.48 | $1.21 | 45.0x | +16% |
| FY2023 Q2 | Jun 30 2023 | $67.28 | $1.13 | 59.5x | +53% |
| FY2023 Q1 | Mar 31 2023 | $51.47 | $0.93 | 55.3x | +42% |
| FY2022 Q4 | Dec 31 2022 | $46.02 | $0.93 | 49.5x | +27% |
| FY2022 Q3 | Sep 30 2022 | $50.68 | $0.96 | 52.8x | +35% |
| FY2022 Q2 | - | $45.55 | $1.01 | 45.1x | +16% |
| FY2022 Q1 | - | $46.47 | $1.25 | 37.2x | -5% |
| FY2021 Q4 | Dec 31 2021 | $50.23 | $1.26 | 39.9x | +2% |
| FY2021 Q3 | - | $53.09 | $1.32 | 40.2x | +3% |
| FY2021 Q2 | Jun 30 2021 | $61.02 | $1.39 | 43.9x | +13% |
| FY2021 Q1 | Mar 31 2021 | $48.78 | $1.16 | 42.1x | +8% |
| FY2020 Q4 | - | $40.50 | $1.04 | 38.9x | -0% |
| FY2020 Q3 | Sep 30 2020 | $32.53 | $0.93 | 35.0x | -10% |
| FY2020 Q2 | - | $26.40 | $0.81 | 32.6x | -16% |
| FY2020 Q1 | - | $24.92 | $0.87 | 28.6x | -26% |
| FY2019 Q4 | - | $35.95 | $0.88 | 40.9x | +5% |
| FY2019 Q3 | Sep 30 2019 | $34.18 | $0.95 | 36.0x | -8% |
| FY2019 Q2 | Jun 30 2019 | $27.98 | $0.91 | 30.7x | -21% |
| FY2019 Q1 | Mar 31 2019 | $31.00 | $1.11 | 27.9x | -28% |
| FY2018 Q4 | Dec 31 2018 | $23.64 | $1.13 | 20.9x | -46% |
| FY2018 Q3 | Sep 30 2018 | $38.74 | $1.04 | 37.3x | -4% |
| FY2018 Q2 | Jun 30 2018 | $33.48 | $1.08 | 31.0x | -20% |
| FY2018 Q1 | Mar 31 2018 | $36.23 | $0.88 | 41.2x | +6% |
| FY2017 Q4 | Dec 31 2017 | $31.84 | $0.85 | 37.5x | -4% |
| FY2017 Q3 | Sep 30 2017 | $37.42 | $0.77 | 48.6x | +25% |
| FY2017 Q2 | Jun 30 2017 | $31.22 | $0.69 | 45.2x | +16% |
| FY2017 Q1 | Mar 31 2017 | $24.63 | $0.60 | 41.0x | +5% |
| FY2016 Q4 | Dec 31 2016 | $25.34 | $0.55 | 46.1x | +18% |
| FY2016 Q3 | Sep 30 2016 | $19.84 | $0.55 | 36.1x | -7% |
| FY2016 Q2 | - | $14.27 | $0.49 | 29.1x | -25% |
| FY2016 Q1 | - | $15.52 | $0.45 | 34.5x | -11% |
| FY2015 Q4 | - | $17.25 | $0.42 | 41.1x | +5% |
| FY2015 Q3 | Sep 30 2015 | $12.19 | $0.40 | 30.5x | -22% |
| FY2015 Q2 | - | $12.06 | $0.34 | 35.5x | -9% |
| FY2015 Q1 | - | $8.38 | $0.32 | 26.2x | -33% |
| FY2014 Q4 | Dec 31 2014 | $7.65 | $0.23 | 33.7x | -13% |
| FY2014 Q3 | - | $6.88 | $0.17 | 41.3x | +6% |
| FY2014 Q2 | Jun 30 2014 | $8.27 | $0.17 | 49.6x | +27% |
| FY2014 Q1 | Mar 31 2014 | $8.07 | $0.15 | 55.0x | +41% |
| FY2013 Q4 | - | $8.01 | $0.21 | 38.1x | -2% |
| FY2013 Q3 | Sep 30 2013 | $6.70 | $0.20 | 33.5x | -14% |
| FY2013 Q2 | Jun 30 2013 | $6.54 | $0.19 | 34.4x | -12% |
| FY2013 Q1 | Mar 31 2013 | $6.20 | $0.18 | 34.4x | -12% |
| FY2012 Q4 | Dec 31 2012 | $5.74 | $0.15 | 38.3x | -2% |
| FY2012 Q3 | Sep 30 2012 | $6.42 | $0.13 | 48.4x | +24% |
| FY2012 Q2 | Jun 30 2012 | $6.00 | $0.17 | 34.8x | -11% |
| FY2012 Q1 | Mar 31 2012 | $5.89 | $0.15 | 38.6x | -1% |
| FY2011 Q4 | Dec 31 2011 | $5.92 | $0.14 | 43.3x | +11% |
| FY2011 Q3 | Sep 30 2011 | $6.22 | $0.24 | 25.5x | -35% |
| FY2011 Q2 | - | $7.07 | $0.25 | 27.8x | -29% |
| FY2011 Q1 | - | $6.81 | $0.31 | 21.7x | -44% |
| FY2010 Q4 | Dec 31 2010 | $6.77 | $0.37 | 18.3x | -53% |
| FY2010 Q3 | - | $7.05 | $0.32 | 22.0x | -44% |
| FY2010 Q2 | Jun 30 2010 | $5.60 | $0.31 | 18.0x | -54% |
| FY2010 Q1 | Mar 31 2010 | $4.50 | $0.28 | 16.0x | -59% |
| FY2009 Q4 | - | $5.00 | $0.10 | 49.6x | +27% |
| FY2009 Q3 | Sep 30 2009 | $4.09 | $0.04 | 102.5x | +163% |
Average P/E for displayed period: 39.0x
LMAT Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
17+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
LMAT — Frequently Asked Questions
Quick answers to the most common questions about buying LMAT stock.
What is LMAT's P/E ratio?
LeMaitre Vascular, Inc. (LMAT) trailing twelve-month P/E ratio is 32.1x, based on TTM diluted EPS of $2.68. The 5-year average P/E is 44.3x and the historical range spans 32.3x to 59.5x.
Is LMAT stock overvalued or undervalued?
LMAT trades at 32.1x P/E, below its 5-year average of 44.3x. At the 0th percentile of its historical range (32.3x–59.5x), the stock is priced at a discount to its own history.
Is LMAT stock expensive?
No, LMAT is not expensive on a historical basis. The current P/E of 32.1x is below the 5-year average of 44.3x and sits at the 0th percentile of its valuation range.
What is LMAT's historical P/E range?
Over the past 5 years, LMAT's P/E ratio has ranged from 32.3x to 59.5x, with a median of 44.2x and an average of 44.3x. The current P/E of 32.1x places the stock at the 0th percentile of this range. Full historical data spans 2009–2026.
How does LMAT's P/E compare to the S&P 500?
LMAT trades at 32.1x P/E versus the S&P 500 median of 24.8x. The 29% premium to the market typically reflects higher expected earnings growth or quality.
How does LMAT's valuation compare to Healthcare peers?
LeMaitre Vascular, Inc. P/E of 32.1x compares to the Healthcare sector median of 23.7x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is LMAT's PEG ratio?
LMAT PEG ratio is 1.66, based on a P/E of 32.1x and EPS growth of 30.6%. A PEG between 1 and 2 suggests valuation aligns with growth expectations — typically considered fair.
What is LMAT's earnings yield?
LMAT earnings yield is 3.12%, the inverse of its 32.1x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.